MedTrace Logo

Compliance Survey of ADHD Medication for Optimal Satisfaction (COSMOS)

NCT00460720 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 591

Last updated 2010-04-28

No results posted yet for this study

Summary

The survey is designed to identify non-compliant Attention Deficit Hyperactivity Disorder (ADHD) patients who are currently on Immediate- Released Methylphenidate (IR-MPH) and observe any change in compliance after treating with other drugs intended to treat ADHD for over 3 weeks

Conditions

  • Attention Deficit Disorder With Hyperactivity

Interventions

OTHER

Observational treatment compliance survey

Observational treatment compliance survey

Sponsors & Collaborators

  • Johnson & Johnson Taiwan Ltd

    lead INDUSTRY

Principal Investigators

  • Johnson & Johnson Taiwan, Ltd. Clinical Trial · Johnson & Johnson Taiwan Ltd

Eligibility

Min Age
6 Years
Max Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Completion
2006-02-28

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00460720 on ClinicalTrials.gov